{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:13:35Z","timestamp":1778825615963,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1006\/clim.2001.5132","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"284-288","source":"Crossref","is-referenced-by-count":51,"title":["Outcome of Intravenous Immunoglobulin-Transmitted Hepatitis C Virus Infection in Primary Immunodeficiency"],"prefix":"10.1006","volume":"101","author":[{"given":"Samiya","family":"Razvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen M.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2001.5132_RF1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(83)90496-8","article-title":"Non A non B hepatitis and intravenous immunoglobulin","volume":"2","author":"Lane","year":"1983","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(85)91430-8","article-title":"Non A, non B hepatitis and intravenous immunoglobulin","volume":"1","author":"Ochs","year":"1985","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF3","first-page":"977","article-title":"Non-A non-B hepatitis after intravenous immunoglobulin","volume":"1","author":"Weiland","year":"1986","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-9343(88)90016-2","article-title":"Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency","volume":"84","author":"Bj\u00f6rkander","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1006\/clim.2001.5132_RF5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Treatment with contaminated immune globulin","volume":"331","author":"Bj\u00f6ro","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5132_RF6","first-page":"1062","article-title":"Non-A non-B hepatitis occurring in agammaglobulinemic patients after intravenous immunoglobulin","volume":"2","author":"Lever","year":"1990","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery persistence and sequelae in hepatitis C virus infection: A perspective on long-term outcome","volume":"20","author":"Allen","year":"2000","journal-title":"Semin. Liver Dis."},{"key":"10.1006\/clim.2001.5132_RF8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: Host, visual and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1006\/clim.2001.5132_RF9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/92.8.433","article-title":"Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia","volume":"92","author":"Bj\u00f6ro","year":"1999","journal-title":"Q. J. Med."},{"key":"10.1006\/clim.2001.5132_RF10","first-page":"263","article-title":"Unusual course of thr hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency","volume":"23","author":"Munoz","year":"1995","journal-title":"Allergol. Immunopathol."},{"key":"10.1006\/clim.2001.5132_RF11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/BF01957899","article-title":"Rapidly progressive hepatitis C in a patient with common variable immunodeficiency","volume":"155","author":"Sumazaki","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1006\/clim.2001.5132_RF12","first-page":"505","volume":"43","year":"1994","journal-title":"MMWR"},{"key":"10.1006\/clim.2001.5132_RF13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0168-8278(05)80328-9","article-title":"Hepatitis C virus transmission by intravenous immunoglobulin","volume":"21","author":"Yap","year":"1994","journal-title":"J Hepatol."},{"key":"10.1006\/clim.2001.5132_RF14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/jama.1996.03540190035026","article-title":"Hepatitis C virus infection associated with administration of intravenous immune globulin: A cohort study","volume":"276","author":"Bresee","year":"1996","journal-title":"JAMA"},{"key":"10.1006\/clim.2001.5132_RF15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1542\/peds.98.2.211","article-title":"Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin","volume":"98","author":"Jonas","year":"1996","journal-title":"Pediatrics"},{"key":"10.1006\/clim.2001.5132_RF16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.1996.v110.pm8613001","article-title":"Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy","volume":"110","author":"Healey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1006\/clim.2001.5132_RF17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2249.1997.508-ce1412.x","article-title":"Clinical outcome of hypogammaglobulinemia patients following outbreak of acute hepatitis C: 2 year followup","volume":"110","author":"Christie","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2001.5132_RF18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/clim.2001.5036","article-title":"Five-year follow-up of patients with primary antibody deficiencies following an outbreak of acute hepatitis C","volume":"99","author":"Chapel","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1006\/clim.2001.5132_RF19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0140-6736(90)91335-8","article-title":"Anti-HCV screening and plasma fractionation: The case against","volume":"335","author":"Finlayson","year":"1990","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(95)91002-6","article-title":"Hepatitis C transmission associated with intravenous immunoglobulin","volume":"345","author":"Yu","year":"1995","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5132_RF21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-2918(96)80192-5","article-title":"Gammagard and reported hepatitis C episodes","volume":"18","author":"Gomperts","year":"1996","journal-title":"Clin. Ther. Suppl. B"},{"key":"10.1006\/clim.2001.5132_RF22","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.286.5446.1954","article-title":"An essential role for BLNK in human B cell development","volume":"286","author":"Minegishi","year":"1999","journal-title":"Science"},{"key":"10.1006\/clim.2001.5132_RF23","first-page":"2094","article-title":"Prevalence of hepatitis C virus infection in the United States","volume":"341","author":"Stroffolini","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5132_RF24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/jhep.2000.9714","article-title":"Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975","volume":"32","author":"Rodger","year":"2000","journal-title":"Hepatology"},{"key":"10.1006\/clim.2001.5132_RF25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2893.2001.00253.x","article-title":"Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C infection","volume":"8","author":"Hu","year":"2001","journal-title":"J. Viral Hepat."},{"key":"10.1006\/clim.2001.5132_RF26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood.V90.3.1309","article-title":"Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: Different prognosis according to the immune status","volume":"90","author":"Rossi","year":"1997","journal-title":"Blood"},{"key":"10.1006\/clim.2001.5132_RF27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.52.1.29","article-title":"Current treatment strategies for chronic hepatitis B and C","volume":"52","author":"Lin","year":"2001","journal-title":"Ann. Rev. Med."},{"key":"10.1006\/clim.2001.5132_RF28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.285.2.193","article-title":"Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta analysis of randomized trial","volume":"285","author":"Cummings","year":"2001","journal-title":"JAMA"},{"key":"10.1006\/clim.2001.5132_RF29","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJM200012073432302","article-title":"Peg interferon alfa 2a in patients with chronic hepatitis C and cirrhosis","volume":"343","author":"Heathcote","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5132_RF30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/gut.48.6.843","article-title":"Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis","volume":"48","author":"Gramenzia","year":"2001","journal-title":"Gut"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601951320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601951320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T20:30:07Z","timestamp":1680553807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661601951320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1521661601951320"],"URL":"https:\/\/doi.org\/10.1006\/clim.2001.5132","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}